R-CHOP is a cancer drug combination. It is a treatment for non-Hodgkin lymphoma or advanced nodular lymphocyte predominant Hodgkin lymphoma (NLPHL).

This trial is looking at acalabrutinib to see if it can improve treatment for people with Richter’s syndrome.

CHOP is a chemotherapy cancer drug combination that includes cyclophosphamide, doxorubicin, vincristine and prednisolone. It is a treatment for non-Hodgkin lymphoma (NHL).

Chemotherapy for non-Hodgkin lymphoma Chemotherapy uses anti cancer (cytotoxic) drugs to destroy cancer cells. The drugs circulate throughout your body in the bloodstream. Chemotherapy is a common treatment for non-Hodgkin lymphoma (NHL). You might have a combination of different chemotherapy drugs. You can have chemotherapy into a vein or as tablets, …

R-GCVP R-GCVP is the name of a cancer drug combination. It includes the drugs below. How to pronounce the drug names are in brackets. R – rituximab (ri-tuk-si-mab) G – gemcitabine (jem-site-uh-been) C – cyclophosphamide (sike-low-foss-fa-mide) V – vincristine (vin-kris-teen) P – prednisolone (pred-nis-oh-lone) It is a treatment for non-Hodgkin lymphoma (NHL). You might …

This trial is looking at whether acalabrutinib can improve treatment for people with a type of non Hodgkin lymphoma called diffuse large B cell (DLBCL).

R-DHAP is a cancer drug combination treatment for high grade non-Hodgkin lymphoma. Find out how you have it and other important information.

Standardised SACT regimen-specific consent forms for Clinicians and healthcare professionals involved with consenting and treating patients with SACT.

Most chemotherapy side effects are temporary and disappear once your treatment is over. For some people, chemotherapy can cause long term changes in the body months or years after treatment.

This trial is trying to find out if a drug called bortezomib can help to stop diffuse large B cell lymphoma (DLBCL) coming back after treatment.